InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Mueller Brian, Chief Financial Officer. Director active across 1 companies, notably Biomarin Pharmaceutical INC. Cumulatively, 9 disclosures have been published. The latest transaction was disclosed on 29 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€46,271576 shares@ €80.33240.0004% mcap13.3% of flow
Common Stock
SEC:0001567619-22-013594:0·
€20,200340 shares@ €59.41150.0002% mcap5.8% of flow
Common Stock
SEC:0001567619-22-009717:0·
011,040 shares0
Common Stock
SEC:0001567619-22-007185:0·
€83,2651,072 shares@ €77.672959.0% of flow
Common Stock
SEC:0001567619-22-002765·
€83,2651,072 shares@ €77.67290.0007% mcap23.9% of flow
Common Stock
SEC:0001567619-22-002765:0·
€40,391576 shares@ €70.123128.6% of flow
Common Stock
SEC:0001567619-21-012800·
€40,391576 shares@ €70.12310.0004% mcap11.6% of flow
Common Stock
SEC:0001567619-21-012800:0·
€17,548341 shares@ €51.460812.4% of flow
Common Stock
SEC:0001567619-21-009606·
€17,548341 shares@ €51.46080.0002% mcap5.0% of flow
Common Stock
SEC:0001567619-21-009606:0·
9 of 9 declarations
About Mueller Brian
Brian Mueller is the Executive Vice President and Chief Financial Officer at BioMarin Pharmaceutical Inc. In this role, he is responsible for the company's financial management and the development of financial strategies. Mueller brings significant expertise in the pharmaceutical sector, contributing to the company's growth and sustainability.
